National Institutes of Health
Government·United States·3 programs
NIH sets aside more than $1.4 billion of its R&D budget for the SBIR and STTR small business programs, funding U.S. small businesses building biomedical innovations from research tools and digital health software to diagnostics, drugs and devices. Non-dilutive: NIH takes no ownership of the business.
What National Institutes of Health funds
Late-stage NIH funding of up to $4,191,495 over up to 3 years, available only to small businesses that already hold an NIH SBIR/STTR Phase II or Phase IIB award.
NIH development award with a $2,153,927 budget guideline over 1 to 3 years, continuing R&D started under Phase I.
NIH feasibility award with a $323,090 budget guideline over 6 months to 2 years, for U.S. small business concerns working on biomedical and health technologies.